THE WEEK AHEAD: NKE EARNINGS; CRON, IQ, NTNX, EWZ
This post is going to be short work, since there aren't many earnings in play for next week, and non-earnings premium selling is somewhat limited ... .
NKE is the only earnings that comes up on my radar for next week (announces on Tuesday after market close). While it has an implied volatility rank of 72, its 30-day isn't exactly "doing it" at 29%. That being said, the slightly short delta, 68% probability of profit, Oct 19th 80/90 short strangle pays 1.72/contract at the mid.
Other top implied volatility underlyings include CRON at 140%, IQ at 60%, and NTNX at 54%, but these underlyings aren't the best in terms of expiry and strike availability, which can make for headaches if you need to roll. I've already experienced some of this in a CRON play; there was no November available after the October monthly, so had to roll all the way out to January, which can be a drag if you're less than the patient type ... . I pretty much knew that it could be a headache going in because of oddball expiry availability, but couldn't pass on the juiciness.
On the non-earnings front: "The Brazilian" -- EWZ continues to be frisky (but not quite as frisky as it was) with a rank of 69 and a 30-day of 47%. The November 29/40 short strangle camped out at the 21 delta has a probability of profit of 70%, break evens of 27.35/41.62, and pays 1.65 -- not bad for an extremely liquid $34 underlying.
NKE is the only earnings that comes up on my radar for next week (announces on Tuesday after market close). While it has an implied volatility rank of 72, its 30-day isn't exactly "doing it" at 29%. That being said, the slightly short delta, 68% probability of profit, Oct 19th 80/90 short strangle pays 1.72/contract at the mid.
Other top implied volatility underlyings include CRON at 140%, IQ at 60%, and NTNX at 54%, but these underlyings aren't the best in terms of expiry and strike availability, which can make for headaches if you need to roll. I've already experienced some of this in a CRON play; there was no November available after the October monthly, so had to roll all the way out to January, which can be a drag if you're less than the patient type ... . I pretty much knew that it could be a headache going in because of oddball expiry availability, but couldn't pass on the juiciness.
On the non-earnings front: "The Brazilian" -- EWZ continues to be frisky (but not quite as frisky as it was) with a rank of 69 and a 30-day of 47%. The November 29/40 short strangle camped out at the 21 delta has a probability of profit of 70%, break evens of 27.35/41.62, and pays 1.65 -- not bad for an extremely liquid $34 underlying.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.